Elevate your confidence by analyzing investor sentiment and stock portfolio shifts, then make your own decisions.

New ADHD Medication Is On Track For NDA Filing Within A Year – Hear From This Biotech's CEO What's Going On With Cingulate Shares Recently? Cingulate Inc. (NASDAQ: CING) shares are soaring Friday.

Reveal insider sentiment with alternative data that tracks buy and sell trades made by top managers and company directors.

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Discover outperforming stocks and invest smarter with Top Smart Score Stocks Filter, analyze, and streamline your search for investment opportunities using Tipranks' Stock Screener Cingulate Inc ...

Enhance your stock picks with dividend metrics like per-share dividends, yield, frequency, payout ratios, and more.

Cingulate Inc. (NASDAQ:CING) shares are surging, trading over 159% higher today. Here’s what’s driving the movement. Why It’s Moving: Cingulate’s stock is soaring following the ...

Cingulate Inc. secures $5 million in financing to support clinical and operational activities, targeting NDA filing for CTx-1301 by mid-2025. Cingulate Inc. has secured $5 million in net proceeds ...